SLS

SELLAS Life Sciences Group (SLS)

About SELLAS Life Sciences Group (SLS)

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Details

Daily high

$5.03

Daily low

$4.84

Price at open

$4.95

52 Week High

$6.14

52 Week Low

$1.36

Market cap

885.3M

Dividend yield

0.00%

Volume

3.4M

Avg. volume

4.3M

P/E ratio

-20.05

SELLAS Life Sciences Group News